INAB logo

IN8bio, Inc. Common Stock


INAB: IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell product candidates for solid and liquid tumors, by employing allogeneic, autologous and genetically modified gamma-delta T cells.


Show INAB Financials

Consumer Interest
SEC Filings

Recent trades of INAB by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quiver Logo

No Whale Activity for this ticker

Institutional Holdings Dashboard

Quarterly net insider trading by INAB's directors and management

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of INAB in WallStreetBets Daily Discussion


Recent insights relating to INAB

CNBC Recommendations

Recent picks made for INAB stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in INAB

Corporate Flights

Flights by private jets registered to INAB